Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis

NCT02702180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Pulmonary Alveolar Proteinosis

Interventions

DRUG: Molgramostim
DRUG: Placebo
DEVICE: PARI eFlow nebulizer system

Sponsor

Savara Inc.